Donald D. Tartre
Nessuna posizione attualmente
Profilo
Donald D.
Tartre worked as Controller, Vice President-Finance & Planning at Agouron Pharmaceuticals LLC from 1997 to 2001.
He then worked as an Audit Manager at Ernst & Young LLP.
From 2001 to 2004, he served as Chief Financial Officer & Vice President at Nventa Biopharmaceuticals Corp.
He then worked as Vice President-Finance & Controller at Gen-Probe, Inc. from 2004 to 2007.
After that, he worked as Senior Vice President-Finance at Solera Holdings LLC and Solera Holdings LLC (Texas).
Finally, he served as Chief Executive Officer at eBioscience, Inc. Mr. Tartre received his undergraduate degree from the University of Southern California.
Precedenti posizioni note di Donald D. Tartre
| Società | Posizione | Fine |
|---|---|---|
| Solera Holdings LLC | Direttore Finanziario/CFO | 02/09/2008 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | 01/11/2007 |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Direttore Finanziario/CFO | 01/01/2004 |
Agouron Pharmaceuticals LLC
 Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Direttore Finanziario/CFO | 01/03/2001 |
eBioscience, Inc.
 eBioscience, Inc. BiotechnologyHealth Technology eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA. | Amministratore Delegato | - |
Formazione di Donald D. Tartre
| University of Southern California | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
| Solera Holdings LLC | Commercial Services |
Solera Holdings LLC (Texas)
 Solera Holdings LLC (Texas) Packaged SoftwareTechnology Services Solera Holdings, Inc. engages in the provision of software and services to the automobile insurance claims processing industry. The firm provides data driven productivity and decision support solutions to other aspects of vehicle ownership such as vehicle validation, driver violation monitoring, vehicle salvage, and electronic titling. The company was founded by Tony Aquila in January 2005 and is headquartered in Westlake, TX. | Technology Services |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Nventa Biopharmaceuticals Corp. discovered, developed and commercialized stress protein-based therapeutic vaccines. The company was headquartered in Victoria, Canada. | Health Technology |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
eBioscience, Inc.
eBioscience, Inc. BiotechnologyHealth Technology eBioscience, Inc. manufactures staple research reagents. The company was founded in 1999 and is headquarter in Santa Clara, CA. | Health Technology |
- Borsa valori
- Insiders
- Donald D. Tartre
